Viewing Study NCT05641259


Ignite Creation Date: 2025-12-24 @ 2:32 PM
Ignite Modification Date: 2025-12-25 @ 7:38 PM
Study NCT ID: NCT05641259
Status: RECRUITING
Last Update Posted: 2024-02-02
First Post: 2022-11-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess Safety and Preliminary Efficacy of LP-108 Combined With Azacitidine In Subjects With AML, MDS, CMML
Sponsor: Guangzhou Lupeng Pharmaceutical Company LTD.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module